ALLMedicine™ Injecting Drug Use Center

May 26th, 2022 - Unintentional drug overdose has increased markedly in the United States. Studies document an association between psychiatric disorder and unintentional overdose; we extend this research through a preliminary test of a causal model of recurrent inj...

May 25th, 2022 - EZ-C's purpose is to determine the effectiveness of patient navigation services during treatment of hepatitis C compared to usual care among opioid substitution therapy (OST) and active injecting drug use (IDU) individuals. To recruit OST and acti...

Apr 19th, 2022 - Background With recent UN reports estimating that as many as 14.2 million individuals inject substances worldwide, injectable drug use continues to be a growing global concern given the increased risk for various health-related consequences faced ...

Apr 19th, 2022 - Background With recent UN reports estimating that as many as 14.2 million individuals inject substances worldwide, injectable drug use continues to be a growing global concern given the increased risk for various health-related consequences faced ...

Apr 18th, 2022 - Evidence regarding the acceptability of contingency management is limited. We investigated the willingness of people who inject drugs to participate in a randomised controlled trial (RCT) involving financial incentives to initiate HCV treatment. E...

May 25th, 2022 - EZ-C's purpose is to determine the effectiveness of patient navigation services during treatment of hepatitis C compared to usual care among opioid substitution therapy (OST) and active injecting drug use (IDU) individuals. To recruit OST and acti...

Apr 14th, 2022 - A pilot two-arm, individual-level, randomised controlled trial to assess the effect of an intervention integrating contingency management (financial incentives) to enhance hepatitis C treatment uptake following dried blood spot hepatitis C RNA tes...

Apr 14th, 2022 - In Australia, hepatitis C virus (HCV)-related morbidity and mortality have doubled in the past decade, with health care costs of $220 million per annum associated with approximately 200,000 chronically infected cases. The majority of new (90%) and...

Mar 31st, 2022 - The ETHOS II Project is a collaborative research project led by the Kirby Institute, UNSW Sydney, in partnership with: The Centre for Social Research in Health, UNSW Sydney NSW Health NSW Users and AIDS Association Hepatitis NSW Australasian Socie...

Aug 17th, 2021 - Among HIV-infected individuals, non-injection drug use (NIDU) is associated with poor HIV medication adherence, greater HIV/AIDS risk behaviors, and increasing non-AIDS mortality. Thus reducing NIDU among HIV infected individuals is critical to th...

Jul 3rd, 2018 - SAN DIEGO – The transition from noninjecting to injecting drug use can be a reversible process, results from a long-term study suggest. “There’s a common stereotype in popular culture and in academic research that once people start injecting drugs.

Feb 3rd, 2015 - Most individuals who use injection drugs inject their drugs intravenously, but subcutaneous injection (ie, "skin-popping") is also common, and intramuscular injection may occur intentionally or when the individual misses the vein or the subcutaneo...

Jun 12th, 2013 - Preexposure prophylaxis (PrEP) with tenofovir disoproxil fumarate nearly halved (48.9%) HIV infection rates in injection drug users, according to a randomized, double-blind, placebo-controlled, phase 3 trial of 2413 participants in Thailand. Kachi...

Jul 27th, 2011 - Worldwide, an estimated 10 million injecting drug users have hepatitis C virus, while about 1. 2 million have hepatitis B virus, based on results from an innovative and comprehensive analysis.

Apr 25th, 2010 - LONDON (Reuters) - Barely a twentieth of the estimated $3.2 billion needed is put into preventing drug users spreading the AIDS virus, experts said on Monday, and the shortfall is fuelling HIV epidemics in parts of Europe and Asia. In a report on ...